CN3OP: an active regimen in patients with relapsed/refractory Hodgkin's lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CN3OP: an active regimen in patients with relapsed/refractory Hodgkin's lymphoma

Published:2000-08 Issue:3 Volume:17 Page:195-202
ISSN:1357-0560
Container-title:Medical Oncology
language:en
Short-container-title:Med Oncol

Author:

Walewski J,Krzyżanowska JB,Kraszewska E,Lampka E,Romejko-Jarosińska J,Miśkiewicz Z,Meder J

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF02780528.pdf

Reference37 articles.

1. Chopra Ret al. The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single-centre eight-year study of 155 patients.Blood 1993;81: 1137–1145.

2. Horning Set al. High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin's disease: analysis of the Stanford University results and prognostic indices.Blood 1997;89: 801–813.

3. Lancet JEet al. Autotransplantation for relapsed or refractory Hodgkin's disease: long-term follow-up and analysis of prognostic factors.Bone Marrow Transplant 1998;22: 265–271.

4. Sweetenham JWet al. High-dose therapy and autologous stem-cell transplantation for adult patients with Hodgkin's disease who do not enter remission after induuction chemotherapy: results in 175 patients reported to the European Group for Blood and Marrow Transplantation.J Clin Oncol 1999;17: 3101–3109.

5. Yuen ARet al. Comparison between conventional salvage therapy and high-dose therapy with autografting for recurrent or refractory Hodgkin's disease.Blood 1997;89: 814–822.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimal treatment for relapsing patients with Hodgkin lymphoma;Expert Review of Hematology;2009-06

2. Salvage Therapy in Hodgkin's Lymphoma;The Oncologist;2007-02-01

3. Perspectives on cancer therapy-induced mucosal injury;Cancer;2004

4. Long-term results of conventional-dose salvage chemotherapy in patients with refractory and relapsed Hodgkin’s disease (Croatian experience);Annals of Oncology;2002-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3